Qube Research & Technologies (QRT)’s Century Therapeutics IPSC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,501	Closed	-$8.71K	–	3868
2025 Q3	$8.71K	Sell	17,501 -50,236	-74%	-$27.1K	﹤0.01%	3355
2025 Q2	$37.8K	Buy	+67,737	New	+$36.3K	﹤0.01%	3192
2024 Q2	–	Sell	-334	Closed	-$1.4K	–	4262
2024 Q1	$1.4K	Buy	334 +326	+4,075%	+$1.38K	﹤0.01%	4018
2023 Q4	$27	Buy	+8	New	+$15	﹤0.01%	4113
2023 Q1	–	Sell	-10,632	Closed	-$54.5K	–	2775
2022 Q4	$54.5K	Buy	+10,632	New	+$100K	﹤0.01%	2126
2021 Q3	–	Sell	-19,979	Closed	-$586K	–	2480
2021 Q2	$586K	Buy	+19,979	New	+$507K	0.01%	1198

Other funds holding IPSC

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IPSC Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Century Therapeutics (IPSC) in Q4 2025, closing a stake of 17,501 shares — an estimated $8.71K sold.

Qube Research & Technologies (QRT) first reported a position in IPSC in Q2 2021 and held it in 6 quarters. The position peaked at $586K in Q2 2021. 47 funds tracked by Wall St. Rank hold IPSC as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining Century Therapeutics position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 17,501 Century Therapeutics shares in Q4 2025, an estimated $8.71K.
Qube Research & Technologies (QRT) first reported a position in Century Therapeutics in Q2 2021 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Century Therapeutics position peaked at $586K in Q2 2021.
47 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.